| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2023 | 30.13% | Barclays | $18 → $16 | Maintains | Overweight |
| 11/13/2023 | 54.53% | Piper Sandler | $20 → $19 | Maintains | Overweight |
| 11/09/2023 | 38.27% | RBC Capital | $19 → $17 | Maintains | Outperform |
| 11/09/2023 | 30.13% | Susquehanna | $18 → $16 | Maintains | Positive |
| 11/09/2023 | 70.8% | Raymond James | $23 → $21 | Maintains | Strong Buy |
| 10/17/2023 | 38.27% | Morgan Stanley | $20 → $17 | Downgrades | Overweight → Equal-Weight |
| 10/16/2023 | 30.13% | B of A Securities | $14 → $16 | Upgrades | Neutral → Buy |
| 10/09/2023 | 46.4% | Citigroup | $15 → $18 | Upgrades | Neutral → Buy |
| 10/02/2023 | 87.07% | Raymond James | $18 → $23 | Maintains | Strong Buy |
| 09/06/2023 | 54.53% | RBC Capital | → $19 | Reiterates | Outperform → Outperform |
| 09/06/2023 | 46.4% | Susquehanna | → $18 | Reiterates | Positive → Positive |
| 09/05/2023 | 54.53% | Stifel | → $19 | Initiates Coverage On | → Buy |
| 08/01/2023 | 62.67% | Morgan Stanley | $20 → $20 | Reiterates | Overweight → Overweight |
| 07/31/2023 | 54.53% | Piper Sandler | $17 → $19 | Maintains | Overweight |
| 07/31/2023 | 54.53% | RBC Capital | → $19 | Reiterates | Outperform → Outperform |
| 07/31/2023 | 62.67% | Morgan Stanley | $20 → $20 | Reiterates | Overweight → Overweight |
| 07/31/2023 | 78.93% | Benchmark | → $22 | Reiterates | Buy → Buy |
| 07/27/2023 | 78.93% | Benchmark | → $22 | Reiterates | Buy → Buy |
| 07/19/2023 | — | Benchmark | Upgrades | Hold → Buy | |
| 07/18/2023 | 22% | Citigroup | $13 → $15 | Maintains | Neutral |
| 07/17/2023 | 62.67% | Morgan Stanley | $19 → $20 | Maintains | Overweight |
| 07/10/2023 | 54.53% | RBC Capital | → $19 | Upgrades | Sector Perform → Outperform |
| 06/28/2023 | 13.87% | Capital One | → $14 | Initiates Coverage On | → Equal-Weight |
| 06/23/2023 | 46.4% | Raymond James | $22 → $18 | Maintains | Strong Buy |
| 06/20/2023 | 54.53% | Morgan Stanley | $18 → $19 | Maintains | Overweight |
| 06/16/2023 | 5.73% | Citigroup | $12 → $13 | Maintains | Neutral |
| 06/16/2023 | 54.53% | RBC Capital | $18 → $19 | Maintains | Sector Perform |
| 06/08/2023 | 30.13% | Barclays | $19 → $16 | Maintains | Overweight |
| 06/02/2023 | 5.73% | Susquehanna | $15 → $13 | Maintains | Positive |
| 05/19/2023 | -2.4% | Citigroup | $14 → $12 | Maintains | Neutral |
| 05/09/2023 | 54.53% | Barclays | $26 → $19 | Maintains | Overweight |
| 05/01/2023 | 54.53% | Piper Sandler | $24 → $19 | Maintains | Overweight |
| 04/28/2023 | 78.93% | Raymond James | $24 → $22 | Maintains | Strong Buy |
| 04/18/2023 | 46.4% | Morgan Stanley | $20 → $18 | Maintains | Overweight |
| 04/03/2023 | 46.4% | Susquehanna | $24 → $18 | Maintains | Positive |
| 03/14/2023 | 95.2% | Susquehanna | → $24 | Reiterates | → Positive |
| 02/22/2023 | 30.13% | Citigroup | $18 → $16 | Maintains | Neutral |
| 02/13/2023 | 62.67% | Morgan Stanley | $22 → $20 | Maintains | Overweight |
| 02/10/2023 | 87.07% | RBC Capital | $24 → $23 | Maintains | Sector Perform |
| 02/10/2023 | 95.2% | Susquehanna | $26 → $24 | Maintains | Positive |
| 01/19/2023 | — | Benchmark | Initiates Coverage On | → Hold | |
| 01/17/2023 | — | Citigroup | Downgrades | Buy → Neutral | |
| 11/01/2022 | 78.93% | Morgan Stanley | $21 → $22 | Maintains | Overweight |
| 10/28/2022 | 111.47% | Barclays | $24 → $26 | Maintains | Overweight |
| 09/26/2022 | 70.8% | Morgan Stanley | $19 → $21 | Maintains | Overweight |
| 08/01/2022 | 54.53% | Morgan Stanley | $18 → $19 | Maintains | Overweight |
| 08/01/2022 | 95.2% | Barclays | $20 → $24 | Maintains | Overweight |
| 07/15/2022 | 9.8% | B of A Securities | → $13.5 | Downgrades | Buy → Neutral |
| 07/13/2022 | 46.4% | Morgan Stanley | $20 → $18 | Maintains | Overweight |
| 07/06/2022 | 70.8% | Citigroup | $17 → $21 | Maintains | Buy |
| 06/08/2022 | 87.07% | Susquehanna | $20 → $23 | Maintains | Positive |
| 06/01/2022 | 85.03% | Piper Sandler | → $22.75 | Downgrades | Overweight → Neutral |
| 05/26/2022 | 62.67% | JP Morgan | → $20 | Upgrades | Underweight → Neutral |
| 05/02/2022 | 62.67% | Morgan Stanley | $18 → $20 | Maintains | Overweight |
| 05/02/2022 | 62.67% | Barclays | $16 → $20 | Maintains | Overweight |
| 04/29/2022 | 62.67% | RBC Capital | $18 → $20 | Maintains | Sector Perform |
| 04/19/2022 | 70.8% | Benchmark | → $21 | Initiates Coverage On | → Buy |
| 04/13/2022 | 62.67% | Piper Sandler | $14.5 → $20 | Maintains | Overweight |
| 04/11/2022 | 46.4% | Morgan Stanley | $13.5 → $18 | Maintains | Overweight |
| 02/15/2022 | 17.93% | Piper Sandler | $10.25 → $14.5 | Maintains | Overweight |
| 02/15/2022 | 22% | Citigroup | $11 → $15 | Maintains | Buy |
| 02/15/2022 | -10.53% | JP Morgan | $9 → $11 | Maintains | Underweight |
| 02/14/2022 | 9.8% | Morgan Stanley | $12.5 → $13.5 | Maintains | Overweight |
| 12/21/2021 | -16.63% | Piper Sandler | $10 → $10.25 | Upgrades | Neutral → Overweight |
| 12/10/2021 | — | Citigroup | Upgrades | Neutral → Buy | |
| 12/07/2021 | -2.4% | Morgan Stanley | $10 → $12 | Upgrades | Equal-Weight → Overweight |
| 11/02/2021 | -14.6% | B of A Securities | $9.25 → $10.5 | Upgrades | Underperform → Buy |
| 10/29/2021 | -2.4% | RBC Capital | $11 → $12 | Maintains | Sector Perform |
| 10/25/2021 | -10.53% | Barclays | $9 → $11 | Maintains | Overweight |
| 10/06/2021 | -18.67% | Citigroup | $8 → $10 | Maintains | Neutral |
| 09/09/2021 | -22.73% | RBC Capital | → $9.5 | Assumes | → Sector Perform |
| 07/09/2021 | -18.67% | Morgan Stanley | $7.5 → $10 | Maintains | Equal-Weight |
| 06/23/2021 | -2.4% | Evercore ISI Group | $8 → $12 | Upgrades | In-Line → Outperform |
| 05/03/2021 | -26.8% | Barclays | $7 → $9 | Upgrades | Equal-Weight → Overweight |
| 04/05/2021 | -34.93% | Citigroup | $9 → $8 | Maintains | Neutral |
| 03/25/2021 | -39% | Morgan Stanley | $5.5 → $7.5 | Maintains | Equal-Weight |
| 01/12/2021 | -47.13% | Citigroup | $6 → $6.5 | Maintains | Neutral |
| 12/15/2020 | -51.2% | Citigroup | $3 → $6 | Maintains | Neutral |
| 08/18/2020 | -63.4% | Citigroup | → $4.5 | Maintains | Neutral |
| 07/24/2020 | -77.63% | Credit Suisse | $2.4 → $2.75 | Maintains | Underperform |
| 07/08/2020 | -71.53% | Morgan Stanley | $2.5 → $3.5 | Maintains | Equal-Weight |
| 05/28/2020 | -67.47% | Piper Sandler | $2 → $4 | Maintains | Neutral |
| 05/28/2020 | -63.4% | Citigroup | $1.9 → $4.5 | Maintains | Neutral |
| 04/24/2020 | -79.67% | CFRA | $6.5 → $2.5 | Reiterates | → Sell |
| 04/24/2020 | -83.73% | Credit Suisse | $2.5 → $2 | Maintains | Underperform |
| 04/24/2020 | -71.53% | RBC Capital | $2.75 → $3.5 | Maintains | Outperform |
| 04/14/2020 | -75.6% | Cowen & Co. | → $3 | Downgrades | Outperform → Market Perform |
| 04/06/2020 | -83.73% | Piper Sandler | $0.8 → $2 | Maintains | Neutral |
| 04/06/2020 | -82.92% | Bernstein | $6.9 → $2.1 | Upgrades | Underperform → Market Perform |
| 04/03/2020 | -84.55% | Citigroup | $2.5 → $1.9 | Maintains | Neutral |
| 03/16/2020 | -79.67% | Morgan Stanley | $11 → $2.5 | Downgrades | Overweight → Equal-Weight |
| 03/10/2020 | — | Raymond James | Downgrades | Strong Buy → Market Perform | |
| 03/09/2020 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 02/10/2020 | -10.53% | Morgan Stanley | $12 → $11 | Maintains | Overweight |
| 02/06/2020 | -47.13% | CFRA | $7.5 → $6.5 | Reiterates | → Sell |
| 01/14/2020 | -39% | Bernstein | → $7.5 | Initiates Coverage On | → Underperform |
| 01/10/2020 | -83.73% | HC Wainwright & Co. | $7.5 → $2 | Maintains | Buy |
| 12/13/2019 | -51.2% | JP Morgan | $7 → $6 | Downgrades | Neutral → Underweight |
| 12/03/2019 | -47.13% | Credit Suisse | $11 → $6.5 | Downgrades | Neutral → Underperform |
| 11/20/2019 | -43.07% | Deutsche Bank | → $7 | Initiates Coverage On | → Sell |
| 10/08/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 10/07/2019 | 5.73% | Morgan Stanley | $14 → $13 | Maintains | Overweight |
| 09/30/2019 | -22.73% | Citigroup | $12 → $9.5 | Downgrades | Buy → Neutral |
| 09/26/2019 | -18.67% | Barclays | → $10 | Initiates Coverage On | → Equal-Weight |
| 09/23/2019 | -2.4% | Citigroup | $13 → $12 | Maintains | Buy |
| 09/12/2019 | — | Wells Fargo | Downgrades | Market Perform → Underperform | |
| 08/07/2019 | — | Scotiabank | Downgrades | Sector Outperform → Sector Perform | |
| 08/02/2019 | -6.47% | Jefferies | $14.5 → $11.5 | Downgrades | Buy → Hold |
| 07/30/2019 | -2.4% | Piper Sandler | $13 → $12 | Maintains | Overweight |
| 07/26/2019 | -10.53% | Credit Suisse | $14 → $11 | Maintains | Neutral |
| 07/12/2019 | 38.27% | Morgan Stanley | $18 → $17 | Maintains | Overweight |
| 06/27/2019 | — | Wells Fargo | Downgrades | Outperform → Market Perform | |
| 04/30/2019 | 54.53% | Citigroup | $20 → $19 | Maintains | Buy |
| 03/11/2019 | — | Goldman Sachs | Initiates Coverage On | → Neutral | |
| 01/17/2019 | -2.4% | JP Morgan | $16 → $12 | Downgrades | Overweight → Neutral |
| 12/20/2018 | — | Societe Generale | Upgrades | Hold → Buy | |
| 12/19/2018 | -2.4% | Credit Suisse | $19 → $12 | Downgrades | Outperform → Neutral |
What is the target price for Patterson-UTI Energy (PTEN)?
The latest price target for Patterson-UTI Energy (NASDAQ: PTEN) was reported by Barclays on November 14, 2023. The analyst firm set a price target for $16.00 expecting PTEN to rise to within 12 months (a possible 30.13% upside). 42 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Patterson-UTI Energy (PTEN)?
The latest analyst rating for Patterson-UTI Energy (NASDAQ: PTEN) was provided by Barclays, and Patterson-UTI Energy maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Patterson-UTI Energy (PTEN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Patterson-UTI Energy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Patterson-UTI Energy was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.
Is the Analyst Rating Patterson-UTI Energy (PTEN) correct?
While ratings are subjective and will change, the latest Patterson-UTI Energy (PTEN) rating was a maintained with a price target of $18.00 to $16.00. The current price Patterson-UTI Energy (PTEN) is trading at is $12.30, which is out of the analyst's predicted range.